Acth (4-10)|CAS 780533|DC Chemicals

Cas No.:	4037-01-8
Chemical Name:	Adrenocorticotropic Hormone (ACTH) (4-10), human
Synonyms:	Glycine, L-methionyl-L-a-glutamyl-L-histidyl-L-phenylalanyl-L-arginyl-L-tryptophyl-;ACTH (4-10);ACTH (4-10), human;ADRENOCORTICOTROPIC HORMONE FRAGMENT 4-10;MET-GLU-HIS-PHE-ARG-TRP-GLY;[2-(3,4-dihydroxyphenyl)-2-oxoethyl]methylammonium chloride;1-(3,4-dihydroxy-phenyl)-2-methylamino-ethanone, hydrochloride;3',4'-Dihydroxy-2-(methylamino)acetophenone hydrochloride;adrenalon hydrochloride;ADRENALONE HCL;adrenalone*HCl;ADRENALONE, HYDROCHLORIDE;adrenocortical hormone (4-10);Adrenone hydrochloride;Epinephrine ketone hydrochloride;Kephrine hydrochloride;Antimicrobial peptide (unknown organism clone WO039857-SEQID-1266);Des-1-serine-des-2-tyrosine-des-3-serine-alpha1-10-corticotropin;Adrenocorticotropic Hormone (ACTH) (4-10), human;HY-P1478;UNII-J48AU3I790;4-10-Semax;corticotropin (4-10);H-Met-Glu-His-Phe-Arg-Trp-Gly-OH;porcine ACTH (4-10);human ACTH (4-10);Msh-acth (4-10);4037-01-8;CS-0044415;MS-31803;4-10-Corticotropin;ACTH - msh (4-10);N-(N-(N(2)-(N-(N-(N-L-Methionyl-L-alpha-glutamyl)-L-histidyl)-L-phenylalanyl)-L-arginyl)-L-tryptophyl)glycine;(5S,8S,11S,14S,17S)-14-((1H-Imidazol-4-yl)methyl)-5-((1H-indol-3-yl)methyl)-17-((S)-2-amino-4-(methylthio)butanamido)-11-benzyl-8-(3-guanidinopropyl)-4,7,10,13,16-pentaoxo-3,6,9,12,15-pentaazaicosane-1,20-dioic acid;Q27281179;GLYCINE, L-METHIONYL-L-.ALPHA.-GLUTAMYL-L-HISTIDYL-L-PHENYLALANYL-L-ARGINYL-L-TRYPTOPHYL-;DTXSID001031210;PD100148;(4S)-4-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-(carboxymethylamino)-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid;CHEMBL2028951;J48AU3I790;ACTH 4-10;Antimicrobial peptide (synthetic US20140296137-SEQ-ID-418);corticotropin 4-10;ACTH4-10;ACTH-MSH (4-10);G12436;GLYCINE, L-METHIONYL-L-ALPHA-GLUTAMYL-L-HISTIDYL-L-PHENYLALANYL-L-ARGINYL-L-TRYPTOPHYL-
SMILES:	CSCCC(N)C(NC(C(NC(C(NC(C(NC(C(NC(C(NCC(O)=O)=O)CC1=CNC2=CC=CC=C12)=O)CCCNC(N)=N)=O)CC3=CC=CC=C3)=O)CC4=CN=CN4)=O)CCC(O)=O)=O
Formula:	C₄₄H₅₉N₁₃O₁₀S
M.Wt:	962.085360000002
Purity:	98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.